background image

Esophageal Cancer Clinical Trials

Find clinical trials for esophageal cancer. Search for esophageal cancer clinical trials in different cities and states across the United States.

Filter
1

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for
Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer,
Location: Beverly Hills CA, Duarte CA, Orange CA, Santa Monica CA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT05983432

Phase1, Recruiting

Tissue Collection Protocol for Gastroesophageal Cancers

for
Esophageal Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT02495337

Recruiting

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

for
Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor,
Location: Orlando FL, Atlanta GA, Boston MA, St Louis MO, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06238479

Phase1, Recruiting

Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

for
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype,
Location: Beverly Hills CA, Tacoma WA
Sponsor: Neonc Technologies, Inc.

Sex: All

Age: 18+

Code: NCT06047379

Phase1, Phase2, Recruiting

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

for
Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene Mutation
Location: Boston MA, Basking Ridge NJ, Middletown NJ, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06123338

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab

for
Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Chicago IL, Fort Wayne IN, Indianapolis IN, Louisville KY,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05005403

Phase1, Recruiting

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

for
Esophageal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06414902

Phase1, Recruiting

Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer

for
Lung Cancer, Esophageal Cancer
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT03094884

Phase1, Recruiting

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab for Patients Who Are Disease Free After Completion of Trimodality Treatment for HER-2+ Cancers of Esophagus & Gastroesophageal Junction

for
Esophageal Adenocarcinoma, Esophageal Cancer,
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT05480384

Phase2, Recruiting

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

for
Healthy Volunteer, Prostate Cancer, Head and Neck Cancer,
Location: Saint Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT04354064

Recruiting